Found 29 matching trials
PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer
PHASE1To learn if the combination of amivantamab and tepotinib can help to contro...
Status
Active Not Recruiting
Location
MD Anderson Cancer Center
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs
PHASE2This is a prospective non-randomized national clinical phase 2 trial that a...
Location
Turku University Hospital Cancer Centre
Bioequivalence of 5 Tablets of 100 mg Versus 2 Tablets of 250 mg TF3 of Tepotinib
PHASE1This study investigated the bioequivalence of the 100 milligrams (mg) and 2...
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
PHASE2This phase II Expanded Lung-MAP treatment trial tests tepotinib with or wit...
Location
Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis
Tepotinib Drug-Drug Interaction Study With Itraconazole in Healthy Participants
PHASE1The purpose of this study was to assess the effect of multiple doses of itr...
Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)
PHASE1This is a multi-center, open-label, randomized, Phase 1b/2 study to determi...
Location
Beijing Cancer Hospital
Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
PHASE2As the 3rd generation, EGFR TKI has become a standard treatment option for ...
Location
Samsung Medical Center
A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors
PHASE1This is a single center, multi-arm, biomarker-driven phase 1 study to asses...
Location
Multiple Locations
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
PHASE2This study was to assess the antitumor activity, safety, tolerability, and ...
Location
Yuma Regional Medical Center
Tepotinib Hepatic Impairment Trial
PHASE1The study investigated the effect of various degrees of hepatic impairment ...